CONDUIT PHARMACEUTICALS INC.

Press Releases Conduit Pharmaceuticals Inc.

Equities

CDT

US20678X1063

Market Closed - Nasdaq Other stock markets 21:00:00 14/06/2024 BST			5-day change	1st Jan Change
1.8 ^USD	-10.89%		-36.62%	-60.44%

06-13	Conduit Pharmaceuticals Set to Join Russell 3000 Index Effective July 1	MT
05-14	Conduit Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Conduit Pharmaceuticals to Join Russell 3000® Index	06-13	GL
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer	03-19	GL
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer	03-19	AQ
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub	03-11	GL
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	01-31	GL
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	01-31	AQ
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference	11-02	GL
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656	11/10/23	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW